Assessment of the coronary flow in patients with non-ST-elevation acute myocardial infarct and angiographic relief of normal coronary arteries;Valutazione del flusso coronarico nei pazienti con infarto miocardico acuto senza sopraslivellamento del tratto ST e rilievo angiografico di coronarie normali

Italian Heart Journal Supplement

Volumn 6, Issue 4, 2005, Pages 205-213

  Carunchio, Alessandro ^a,b   Ricci, Roberto ^a   Mazzarotto, Pietro ^a   Danesi, Alessandro ^a   Caferri, Giorgia ^a   Ferraironi, Alessandro ^a   Faina, Elena ^a   Ceci, Vincenzo ^a  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

Coronary artery; Coronary blood flow; Myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ST SEGMENT ELEVATION;

CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 29244439319     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Bruschke AV, Bruyneel KJ, Bloch A, van Herpen G. Acute myocardial infarction without obstructive coronary artery disease demonstrated by selective cinearteriography. Br Heart J 1971; 33: 585-94.
2. Da Costa A, Isaaz K, Faure E, Mourot S, Cerisier A, Lamaud M. Clinical characteristics, aetiological factors and long-term prognosis of myocardial infarction with an absolutely normal coronary angiogram: a 3-year follow-up study of 91 patients. Eur Heart J 2001; 22: 1459-65.
3. Erlebacher JA. Transmural myocardial infarction with "normal" coronary arteries. Am Heart J 1979; 98: 421-30.
4. Lindsay J Jr, Pichard AD. Acute myocardial infarction with normal coronary arteries. Am J Cardiol 1984; 54: 902-4.
5. Proudfit WL, Bruschke VG, Sones FM Jr. Clinical course of patients with normal and slightly or moderately abnormal coronary arteriograms: 10-years follow-up of 521 patients. Circulation 1980; 62: 712-7.
6. Thompson SI, Vieweg WV, Alpert JS, Hagan AD. Incidence and age distribution of patients with myocardial infarction and normal coronary arteriograms. Cathet Cardiovasc Diagn 1977; 3: 1-9.
7. Raymond R, Lynch J, Underwood D, Leatherman J, Razavi M. Myocardial infarction and normal coronary arteriography: 10 year clinical and risk analysis of 74 patients. J Am Coll Cardiol 1988; 11: 471-7.
8. Alpert JS. Myocardial infarction with angiographically normal coronary arteries. Arch Intern Med 1994; 154: 265-9.
9. Fournier JA, Sanchez-Gonzalez A, Quero J, et al. Normal angiogram after myocardial infarction in young patients: a prospective clinical-angiographic and long-term follow-up study. Int J Cardiol 1997; 60: 281-7.
10. Zimmerman FH, Cameron A, Fisher LD, Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Registry). J Am Coll Cardiol 1995; 26: 654-61.
11. Fournier JA, Sanchez A, Quero J, Fernandez-Cortacero JA, Gonzales-Barbero A. Myocardial infarction in men aged 40 years or less: a prospective clinical-angiographic study. Clin Cardiol 1996; 19: 631-6.
12. Cheitlin MD, McAllister HA, de Castro CM. Myocardial infarction without atherosclerosis. JAMA 1975; 231: 951-8.
13. Gersh BJ, Bassendine MF, Forman R, Walls RS, Beck W. Coronary artery spasm and myocardial infarction in the absence of angiographically demonstrable obstructive coronary disease. Mayo Clin Proc 1981; 56: 700-8.
14. Vincent GM, Anderson JL, Marshall HW. Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med 1983; 309: 220-3.
15. Conti CR. Myocardial infarction: thoughts about pathogenesis and the role of coronary spasm. Am Heart J 1985; 110: 187-93.
16. Da Costa A, Guy JM, Rousset H, et al. Antiphospholipids and the heart. Arch Mal Coeur Vaiss 1993; 86: 1256-7.
17. Holm J, Zoller B, Svensson PJ, et al. Myocardial infarction associated with homozygous resistance to activated protein C. Lancet 1994; 344: 952-3.
18. Kyriakidis M, Androulakis A, Triposkiadis F, et al. Lack of a thrombotic tendency in patients with acute myocardial infarction and angiographically normal coronary arteries. Cardiology 1995; 86: 22-4.
19. Ardissino D, Peyvandi F, Merlini PA, Colombi E, Mannucci PM. Factor V (Arg 506 → Gln) mutation in young survivors of myocardial infarction. Thromb Haemost 1996; 75: 701-2.
20. Da Costa A, Tardy-Poncet B, Isaaz K, et al. Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries. Heart 1998; 80: 338-40.
21. Mansourati J, Da Costa A, Munier S, et al. Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thromb Haemost 2000; 83: 822-5.
22. Gonzales M, Herandez I, Aranda JM, Linares E, Cortes F, Contran G. Acute myocardial infarction due to intracoronary occlusion after elective cardioversion of atrial fibrillation in a patient with angiographically nearly normal coronary arteries. Am Heart J 1981; 102: 932-4.
23. Galderisi M, Cicala S, De Simone L, et al. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy. Ital Heart J 2001; 2: 677-84.
24. Di Clemente D, Borghi A, Morgagni CL, Costa GM, Rusticali G, Bugiardini R. Myocardial infarct with normal coronary vessels: an association with dysfunction of the coronary microcirculation. Cardiologia 1994; 39: 827-34.
25. Regan TJ, Wu CF, Weisse AB, Moschos CB, Ahmed SS, Lyons MM. Acute myocardial infarction in toxic cardiomyopathy without coronary obstruction. Circulation 1975; 51: 453-61.
26. Zainea M, Duvernoy WF, Chauhan A, David S, Soto E, Small D. Acute myocardial infarction in angiographically normal coronary arteries following induction of general anesthesia. Arch Intern Med 1994; 154: 2495-8.
27. Yazici M, Demircan S, Aksakal E, et al. Plasma insulin, glucose and lipid levels, and their relations with corrected TIMI frame count in patients with slow coronary slow flow. Anadolu Kardiyol Derg 2003; 3: 222-6.
28. Isner JM, Estes NA III, Thompson PD, et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986; 315: 1438-43.
29. Weber JE, Hollander JE, Murphy SA, Braunwald E, Gibson CM. Quantitative comparison of coronary artery flow and myocardial perfusion in patients with acute myocardial infarction in the presence and absence of recent cocaine use. J Thromb Thrombolysis 2002; 14: 239-45.
30. Kelly RF, Sompalli V, Sattar P, Khankari K. Increased TIMI frame counts in cocaine users: a case for increased microvascular resistance in the absence of epicardial coronary disease or spasm. Clin Cardiol 2003; 26: 319-22.
31. Bertrand ME, Simoons ML, Fox KA, et al, for the Task Force of the ESC. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002; 23: 1809-40.
32. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-42.
33. PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998; 339: 436-43.
34. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-Plus) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998; 338: 1488-97.
35. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 1997; 349: 1429-35.
36. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985; 31: 932-6.
37. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
38. Anderson JL, Karagounis LA, Becker LC, Sorensen SG, Menlove RL, for the TIMI-3 Investigators. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction: ventriculographic, enzymatic, and electrocardiographic evidence from the TIMI-3 study. Circulation 1993; 87: 1829-39.
39. Gibson CM, Cannon CP, Daley WL, et al. The TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-88.
40. Chesebro J, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial. Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142-54.
41. Nava Lopez G, Monteverde C, Jauregui R, et al. X syndrome. Angiographic findings. Arch Inst Cardiol Mex 1989; 59: 257-65.
42. Diver D, Bier J, Ferriera P, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA trial). Am J Cardiol 1994; 74: 531-7.
43. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon - a new coronary microvascular disorder. Cardiology 2002; 97: 197-202.
44. Beltrame JF, Limaye SB, Wuttke RD, Horowitz JD. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J 2003; 146: 84-90.
45. Tambe AA, Demani MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries: a new angiographic finding. Am Heart J 1972; 84: 66-71.
46. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histological evidence for small-vessel coronary artery disease in patients with angina and patent large coronary arteries. Circulation 1986; 74: 964-72.
47. Mangieri E, Macchiarelli G, Ciavolella M, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996; 37: 375-81.
48. Larkin SW, Clarke JG, Keogh BE, et al. Intracoronary endotherm induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol 1989; 64: 956-8.
49. Clarke J, Davies G, Kervin R, et al. Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet 1987; i: 1057-9.
50. Ge J, Erbel R, Gerber T, et al. Intravascular ultrasound imaging of angiographic ally normal coronary arteries: a prospective study in vivo. Br Heart J 1994; 71: 572-8.
51. Pekdemir H, Cin VG, Cicek D, et al. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol 2004; 59: 127-33.
52. Abaci A, Oguzhan A, Eroyl NK, Ergin A. Effect of potential confounding factors on the thrombolysis in myocardial infarction (TIMI) trial frame count and its reproducibility. Circulation 1999; 100: 2219-23.